acmefirewoodis...(put something here)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Big picture view says the share price will be above .35 within three months or sooner.
Twitter: @AmarantusBio
Opens above .15 on Thursday.
"Patience is a virtue."
Twitter: @AmarantusBio
The announcement of a partnership with Becton Dickinson for LymPro would take the share price to the .35 range in a day.
Potential $500,000,000 annual market.
Twitter: @AmarantusBio
p.s. Tomorrow's C.E.O./Chairman's blog launches the company into 2014.
I'd wait to buy GSS below .35 for a "buy and hold" investment. Even then if gold doesn't stay above $1,100 the company may be a candidate for bankruptcy.
It's difficult for a company to operate with a product that it has no control over the selling price.
That can't be true. I haven't been here for eighteen months.
p.s. I suggest you rebuy at the open.
Same old fluff for eighteen months?
I guess you've missed the press releases over the last four months.
It really sucks when someone sells a stock only to have it move 40-50% higher in the next trading session.
Twitter: @AmarantusBio
p.s. You really don't understand what is happening with AMBS. Good luck getting back in under a dime.
Everyone seems to want a cheaper ticket.
It can also make millionaires out of individuals who were former billionaires.
I asked Gerald about the company receiving funds from the G.E./N.F.L. group and his response was that the company was well positioned to receive grant funds once the group decided how much and to whom to award the funds. I would expect it will happen during the first quarter of 2014.
The other side of the gold coin:
"The Gold Rush is Over and Gold Bugs Know It"
http://www.fool.com/investing/general/2013/12/29/the-gold-rush-is-over.aspx
"The Gold Rush is Over and Gold Bugs Know It"
http://www.fool.com/investing/general/2013/12/29/the-gold-rush-is-over.aspx
"The Gold Rush is Over and Gold Bugs Know It"
http://www.fool.com/investing/general/2013/12/29/the-gold-rush-is-over.aspx
I'm surprised that a show such as "60 Minutes" hasn't done a segment on Gerald and the company. Possibly in 2014?
Everyone is entitled to their opinion. That is what makes stocks go up and down.
Your opinion is that .075 makes sense. Why not expect some profit taking from the last two days 40% jump in the share price and place a limit buy order at .065 or less? Or a major gap higher to .10?
As I stated, opinions make for someone buying and someone selling.
All IMHO.
p.s. I guess we'll both know tomorrow morning.
I think it's a coin flip at the current price especially if you're considering buying for more than a day trade.
Canaccord still has a sell rating on the stock with a .20 price target. I'm surprised that they haven't changed it in one direction or the other.
To anyone wanting to buy shares tomorrow I would suggest placing a limit buy order above .085 for the open.
A close in the .13-.15 range wouldn't surprise me.
2014 will be exciting for the AMBS shareholders.
"Patience is a virtue."
Twitter: @AmarantusBio
p.s. Hiring Marcum as the company's new accounting firm is a major positive for the company especially with the uplisting to the NASDAQ in 2014 and anticipated "big pharma" partnerships.
http://www.marcumllp.com/
Zacks has a forecasted loss for the company.
The bottom is in on the share price.
"The trend is your friend."
AMBS will be the "2014 Stock of the Year".
Twitter: @AmarantusBio
Monday may be the last day that the share price is under a dime.
2014 will be a tremendous year for the AMBS shareholders.
Twitter: @AmarantusBio
p.s. AMBS is still the most undervalued stock in the market.
All IMHO.
The company has no choice but to continue to operate even if it's at a loss. To do otherwise would invite the government to nationalize the mines.
The world of politics.
Big Pharma Partnerships + Uplisting to NASDAQ = National Accounting Firm Required
Marcum (New York based) ranks 16th in the U.S. It also has a consulting division which handles such things as partnerships and mergers and acquisitions.
Connect the dots.
Gerald's plan is working.
Add a few shares at the open on Monday. It may be possible to get in under a dime although I doubt it. A close in the .12-.15 range is reasonable to expect.
Twitter: @AmarantusBio
p.s. Yesterday's short volume was over 5,000,000 shares. The shorts need millions of shares to cover.
I think anyone who sold today or yesterday and is on the sidelines waiting for a drop in the share price to buy back their position is in for a big disappointment.
I think the share price opens above .08 on Monday and moves up from there. Try to get in at the open so as not to have to chase it too much higher. A close above .10 is realistic.
2014 will be a year to be remembered by the AMBS shareholders. A very happy "New Year" awaits us.
"Patience is a virtue."
Twitter: @AmarantusBio
Amarantus Hires The Accounting Firm Ranked #16:
http://www.adp.com/accountant/tools-and-resources/~/media/Accountant/docs/ADP_Accounting-Today_2013-Top-100-Firms.ashx#page=18&zoom=auto,0,792
Gerald continues to do things right.
Partnerships require a reputable accounting firm.
"Patience is a virtue."
.10-.12 on Monday.
Have a great weekend!!!
Twitter: @AmarantusBio
Still isn't able to hold gains and move higher.
Partnership with Becton Dickinson for LymPro or a partnership with Novartis for MANF will make the additional shares irrelevant.
A few more shares in the float will be beneficial to the up listing to the NASDAQ.
"Patience is a virtue."
Twitter: @AmarantusBio
"AMBS"
Up almost 25% today in anticipation of the C.E.O./Chairman's blog on 12/31 which is expected to detail the company's plans for 2014.
Potential partnership(s), grant funding, and an up listing to the NASDAQ in 2014 are all possible topics.
Twitter: @AmarantusBio
Today's accumulation appears to be very legitimate and with purpose.
Tomorrow will be a good test. A close above .075 tomorrow would indicate .10 next week.
IMHO.
Twitter: @AmarantusBio
The word is getting out!!!
"Concussions in the NFL Adding Some Much Needed Attention to Brain Conditions"
http://equities.infinitenine.com/editors-desk/stocks/healthcare/concussions-in-the-nfl-adding-some-much-needed-attention-to-brain-conditions
.12-.15 within four weeks.
Twitter: @AmarantusBio
The shorts are not going to like the C.E.O./Chairman's blog which will be posted on 12/31.
Trust me when I say this.
Twitter: @AmarantusBio
Gerald may well be the "2014 Bio-Tech C.E.O. of the Year".
As Gerald stated, "The problem that most small cap bio-techs face is that they have limited options where AMBS has just the opposite situation as it has numerous options."
Twitter: @AmarantusBio
December 31,2013.
The day that will change AMBS forever?
2014 will be a very good year for the AMBS shareholders.
Remember what Gerald said, "Today someone may offer you "X" when in six months they will offer you 100 times "X"."
"Patience is a virtue."
All IMHO.
p.s. I'm holding my shares for 100 times "X".
The word is getting out to the market about the tremendous potential that the company has with LymPro and MANF. The company is substantially undervalued. Just ask Jason Napadano.
I still believe that 99% of the individuals that will own shares in AMBS two years from now still haven't heard about the company.
Anyone buying shares today is getting in at the bottom.
All IMHO.
Twitter: @AmarantusBio
C.E.O./Chairman's blog on 12/31 is expected to present the game plan for 2014 plus updates on progress with Becton Dickinson with LymPro and possibly a disclosure as to Novartis and MANF for diabetes and additional topics currently unknown.
J.P. Morgan Healthcare Conference in January and the T.B.I. presentation at the United Nations will only garner additional exposure for the company.
Also the market in general is finding out about the tremendous potential that the company offers with such a low share price and market cap. LymPro and MANF could be worth billions.
Twitter: @AmarantusBio
Gerald could blow the roof off the share price on 12/31.
"Patience is a virtue."
p.s. Jason Napadano said that .20 was the price prior to the diabetes news. .40 now?
C.E.O./Chairman's blog on December 31 will be the most important one that Gerald has published.
I'm expecting 2014 will be the key formative year in the company's future.
"Patience is a virtue."
Twitter: @AmarantusBio
"Is This Year’s Plunge in Gold Prices Just the Beginning?"
http://www.fool.sg/2013/12/26/is-this-years-plunge-in-gold-prices-just-the-beginning/?source=s76yhocs0070001
"Is This Year’s Plunge in Gold Prices Just the Beginning?"
http://www.fool.sg/2013/12/26/is-this-years-plunge-in-gold-prices-just-the-beginning/?source=s76yhocs0070001
"Why Gold And Silver Will Break To New Lows, Then Rise"
http://seekingalpha.com/article/1915451-why-gold-and-silver-will-break-to-new-lows-then-rise
p.s. Doesn't seem like Christmas in L.A. 80 degrees today.
"Why Gold And Silver Will Break To New Lows, Then Rise"
http://seekingalpha.com/article/1915451-why-gold-and-silver-will-break-to-new-lows-then-rise
p.s. Doesn't seem like Christmas in L.A. 80 degrees today.